Pfizer booster

Israel approves 4th vaccine dose for most vulnerable

Last week, Chile announced that it would start offering a fourth dose in February.

published on : 31st December 2021

Pfizer seeks US approval for Covid boosters for ages 16-17 amid Omicron concerns

Experts are concerned that the pattern of mutations detected on the Omicron variant will mean that the protection generated by the current generation of vaccines may take a partial hit.

published on : 1st December 2021

EU starts evaluation for J&J Covid vaccine booster 

Two other booster shots with vaccines made by Pfizer/Biontech and Moderna have already been approved for use in the EU.

published on : 22nd November 2021

Pfizer asks FDA to greenlight COVID-19 booster shots for all adults

The current rules: People who initially received Pfizer or Moderna vaccinations are eligible for a booster six months later if they’re 65 or older, or are at high risk of COVID-19.

published on : 10th November 2021

EU regulator OKs Pfizer vaccine booster for 18 and older

The European Medicines Agency said the booster doses “may be considered at least 6 months after the second dose for people aged 18 years and older."

published on : 5th October 2021

Bahrain offers Pfizer booster for some who got Chinese shots

The mixing of vaccines comes as the Mideast island nation struggles through its worst wave of the virus despite being one of the top countries in the world in per-capita inoculations.

published on : 3rd June 2021